Lapatinib 50 mg | Purity Not Available StressMarq Biosciences Dual EGFR/HER2 Tyrosine Kinase Inhibitor More Information Supplier Page × Lapatinib
Chaetocin 200 µg | Purity Not Available StressMarq Biosciences Methyltransferase inhibitor More Information Supplier Page × Chaetocin
Safinamide 25 mg | Purity Not Available StressMarq Biosciences MAO-B Inhibitor More Information Supplier Page × Safinamide
(±)-Warfarin D5 (phenyl D5) inquiry | Purity Not Available Alfa Chemistry More Information Supplier Page × (±)-Warfarin D5 (phenyl D5)
(±)-Warfarin D5 (phenyl D5) 100 µg/mL in Acetonitrile inquiry | Purity Not Available Alfa Chemistry More Information Supplier Page × (±)-Warfarin D5 (phenyl D5) 100 µg/mL in Acetonitrile
(±)-Warfarin Sodium Clathrate 1 g | ≥98% LKT Laboratories, Inc. Coumarin; VKORC1 inhibitor. More Information Supplier Page × (±)-Warfarin Sodium Clathrate
(±)-Warfarin Sodium Clathrate 10 g | ≥98% LKT Laboratories, Inc. Coumarin; VKORC1 inhibitor. More Information Supplier Page × (±)-Warfarin Sodium Clathrate
(±)-Warfarin Sodium Clathrate 25 g | ≥98% LKT Laboratories, Inc. Coumarin; VKORC1 inhibitor. More Information Supplier Page × (±)-Warfarin Sodium Clathrate
(±)-Warfarin-d5 1 mg | ≥99% Cayman Chemical An internal standard for the quantification of warfarin More Information Supplier Page × (±)-Warfarin-d5
(±)-Warfarin-d5 500 µg | ≥99% Cayman Chemical An internal standard for the quantification of warfarin More Information Supplier Page × (±)-Warfarin-d5
(±)-WIN 55,212 (mesylate) 50 mg | ≥98% Cayman Chemical A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3 More Information Supplier Page × (±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 25 mg | ≥98% Cayman Chemical A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3 More Information Supplier Page × (±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 10 mg | ≥98% Cayman Chemical A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3 More Information Supplier Page × (±)-WIN 55,212 (mesylate)